Gadolinium-Loaded Nanoparticles Engineered from Microemulsion Templates

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Drug Development and Industrial Pharmacy

• Publication date

  2002-01-01

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1081/DDC-120002847PMID 12026224
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor-bearing mice

  2004cited by this paper
• Defining the drug incorporation properties of PLA-PEG nanoparticles.

  2000cited by this paper
• Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor.

  2000cited by this paper
• Scale-up of the preparation process of solid lipid nanospheres. Part I.

  2000cited by this paper
• Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

  2000cited by this paper
• Studies on the cyclosporin A loaded stearic acid nanoparticles.

  2000cited by this paper
• Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin.

  2000cited by this paper
• Chitosan-Gadopentetic Acid Complex Nanoparticles for Gadolinium Neutron-Capture Therapy of Cancer: Preparation by Novel Emulsion-Droplet Coalescence Technique and Characterization

  1999cited by this paper
• Preparation of lecithin microcapsules by a dilution method using the Wurster process for intraarterial administration in gadolinium neutron capture therapy.

  1999cited by this paper
• Biodistribution of gadolinium incorporated in lipid emulsions intraperitoneally administered for neutron-capture therapy with tumor-bearing hamsters.

  1999cited by this paper
• The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.

  1998cited by this paper
• Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery.

  1998cited by this paper
• Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.

  1998cited by this paper
• Effect of bovine serum on the phase transition temperature of cholesterol-containing liposomes.

  1998cited by this paper
• NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium(III) complexes.

  1998cited by this paper
• Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment.

  1998cited by this paper
• Delivery of Molecular and Cellular Medicine to Solid Tumors

  1997cited by this paper
• Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles

  1997cited by this paper
• Preparation of microemulsions using polyglycerol fatty acid esters as surfactant for the delivery of protein drugs.

  1996cited by this paper
• Nanoparticles as adjuvants for vaccines.

  1995cited by this paper
• Lipid Microemulsions for Improving Drug Dissolution and Oral Absorption: Physical and Biopharmaceutical Aspects

  1995cited by this paper
• Boron neutron capture therapy of primary and metastatic brain tumors

  1994cited by this paper
• Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue.

  1993cited by this paper
• Gadolinium as a neutron capture therapy agent.

  1992cited by this paper
• Transport calculations of depth-dose distributions for gadolinium neutron capture therapy.

  1992cited by this paper
• High performance liquid chromatographic analysis of liposome stability.

  1990cited by this paper
• New thermal neutron capture therapy for malignant melanoma: melanogenesis-seeking 10B molecule-melanoma cell interaction from in vitro to first clinical trial.

  1989cited by this paper
• Nanoparticles in drug delivery.

  1987cited by this paper

• Lipid-based nanomedicines for the treatment of bacterial respiratory infections: current state and new perspectives.

  2024cites this paper
• An Overview on Topical Administration of Carotenoids and Coenzyme Q10 Loaded in Lipid Nanoparticles

  2021cites this paper
• Formation of a lanthanoid complex shell on a nanoparticulate wax core

  2020cites this paper
• Nanopore and Nanoparticle Formation with Lipids Undergoing Polymorphic Phase Transitions.

  2020cites this paper
• Glaucoma: Management and Future Perspectives for Nanotechnology-Based Treatment Modalities.

  2020cites this paper
• Novel Carborane Compounds Based on Cyclooxygenase‐2 Inhibitors for Effective Boron Neutron Capture Therapy of Tongue Squamous Cell Carcinoma

  2020cites this paper
• Rationally designed carbohydrate-occluded epitopes elicit HIV-1 Env-specific antibodies

  2019cites this paper
• Bortezomib-loaded solid lipid nanoparticles: preparation, characterization, and intestinal permeability investigation

  2018cites this paper
• Gadolinium nanoparticles as diagnostic and therapeutic agents: Their delivery systems in magnetic resonance imaging and neutron capture therapy

  2018cites this paper
• Preparation of emulsifying wax/glyceryl monooleate nanoparticles and evaluation as a delivery system for repurposing simvastatin in bone regeneration

  2018cites this paper
• Solid Lipid Nanoparticles System: An Overview

  2016cites this paper
• Mixed Polyethylene Glycol-Modified Breviscapine-Loaded Solid Lipid Nanoparticles for Improved Brain Bioavailability: Preparation, Characterization, and In Vivo Cerebral Microdialysis Evaluation in Adult Sprague Dawley Rats

  2014cites this paper
• A critical review of lipid-based nanoparticles for taxane delivery.

  2013cites this paper
• Contributory roles of innate properties of cetyl alcohol/gelucire nanoparticles to antioxidant and anti-inflammation activities of quercetin

  2013cites this paper
• Boron and Gadolinium Neutron Capture Therapy

  2013cites this paper
• Solid Lipid Nanoparticles for Drug Delivery

  2013cites this paper
• Antitumor effect of novel gallium compounds and efficacy of nanoparticle-mediated gallium delivery in lung cancer.

  2012cites this paper
• Lipid nanoparticles for cancer therapy: state of the art and future prospects

  2012cites this paper
• Chapter 2 – Structural control of nanoparticles

  2012cites this paper
• Drug-Loaded Lipid Nanoparticles for Improved Cancer Treatment: Engineering, In-Vitro, and In-Vivo Evaluation

  2012cites this paper
• Development of nanostructured lipid carriers for controlled delivery of mefenamic acid

  2012cites this paper
• Blood‐Pool and Targeting MRI Contrast Agents: From Gd‐Chelates to Gd‐Nanoparticles

  2012cites this paper
• Scope of nanotechnology-based radiation therapy and thermotherapy methods in cancer treatment.

  2012cites this paper
• Biocompatibility, efficacy and biodistribution of Gelucire-stabilized nanoparticles engineered for docetaxel delivery.

  2012cites this paper
• In vitro and in vivo assessment of targeting lipid-based nanoparticles to the epidermal growth factor-receptor (EGFR) using a novel Heptameric ZEGFR domain.

  2012cites this paper
• Novel method to label solid lipid nanoparticles with 64cu for positron emission tomography imaging.

  2011cites this paper
• Physicochemical characterization of nanotemplate engineered solid lipid nanoparticles.

  2011cites this paper
• EVALUATION OF THE PHYSICOCHEMICAL PROPERTIES AND STABILITY OF SOLID LIPID NANOPARTICLES DESIGNED FOR THE DELIVERY OF DEXAMETHASONE TO TUMORS

  2011cites this paper
• Synthesis of gadolinium nanoscale metal-organic framework with hydrotropes: manipulation of particle size and magnetic resonance imaging capability.

  2011cites this paper
• Development of nanostructured lipid carriers (NLC) for controlled delivery of meloxicam

  2010cites this paper
• Targeted near-IR QDs-loaded micelles for cancer therapy and imaging.

  2010cites this paper
• LIPID-BASED PACLITAXEL AND DOXORUBICIN NANOPARTICLES TO OVERCOME P-GP-MEDIATED DRUG RESISTANCE IN SOLID TUMORS

  2009cites this paper
• Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia.

  2009cites this paper
• Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization.

  2009cites this paper
• Polymer-modified gadolinium metal-organic framework nanoparticles used as multifunctional nanomedicines for the targeted imaging and treatment of cancer.

  2009cites this paper
• Biocompatible microemulsions for fabrication of glyceryl monostearate solid lipid nanoparticles (SLN) of tretinoin.

  2009cites this paper
• Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers.

  2009cites this paper
• Morphology of ionic microemulsions: comparison of SANS studies and the net-average curvature (NAC) model

  2009cites this paper
• Nanotechnology in Drug Development and Life Cycle Management

  2009cites this paper
• TARGETING THE METAL CHELATOR D-PENICILLAMINE TO EXPLOIT THE ELEVATED COPPER AND OXIDATIVE STRESS ASSOCIATED WITH CANCER

  2008cites this paper
• STRUCTURAL CONTROL OF NANOPARTICLES

  2008cites this paper
• Nanoporous and Nanosize Materials for Drug Delivery Systems

  2007cites this paper
• Preparation and Characterization of Nickel Nanoparticles for Binding to His-tag Proteins and Antigens

  2007cites this paper
• Gd nanoparticulates: from magnetic resonance imaging to neutron capture therapy

  2007cites this paper
• Nanoparticles for Neutron Capture Therapy of Cancer

  2007cites this paper
• In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors.

  2006cites this paper
• PHARMACEUTICALLY ENGINEERED NANOPARTICLES FOR ENHANCING IMMUNE RESPONSES TO HIV-1 TAT AND GAG p24 PROTEINS

  2006cites this paper
• Gadolinium incorporated reconstituted chylomicron emulsion for potential application in tumor neutron capture therapy.

  2006cites this paper
• Nanoparticles for cancer therapy and diagnosis

  2006cites this paper
• 1 – Nanoparticle technologies and applications

  2006cites this paper
• The blood-brain barrier and brain drug delivery.

  2006cites this paper
• Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases.

  2005cites this paper
• Blood Compatibility of Cetyl Alcohol/Polysorbate-Based Nanoparticles

  2005cites this paper
• Aqueous liquid scintillation counting with fluor-containing nanosuspensions.

  2004cites this paper
• Nanoparticle Surface Charges Alter Blood–Brain Barrier Integrity and Permeability

  2004cites this paper
• Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice.

  2004cites this paper
• Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells.

  2004cites this paper
• Paclitaxel nanoparticles for the potential treatment of brain tumors.

  2004influential citation
• Boron and gadolinium neutron capture therapy

  2004cites this paper
• Specific association of thiamine-coated gadolinium nanoparticles with human breast cancer cells expressing thiamine transporters.

  2003cites this paper
• In Vivo and in Vitro Assessment of Baseline Blood-Brain Barrier Parameters in the Presence of Novel Nanoparticles

  2003cites this paper
• Influence of formulation parameters on gadolinium entrapment and tumor cell uptake using folate-coated nanoparticles.

  2003cites this paper
• Brain uptake of thiamine-coated nanoparticles.

  2003cites this paper
• Physical Characterization and Macrophage Cell Uptake of Mannan-Coated Nanoparticles

  2003cites this paper
• In Situ Blood–Brain Barrier Transport of Nanoparticles

  2003influential citation
• Drug delivery to the central nervous system: a review.

  2003cites this paper
• Nanotemplate Engineering of Cell Specific Nanoparticles

  2003influential citation
• Intranasal administration of plasmid DNA‐coated nanoparticles results in enhanced immune responses

  2002cites this paper
• Coating of cationized protein on engineered nanoparticles results in enhanced immune responses.

  2002cites this paper
• Engineering tumor-targeted gadolinium hexanedione nanoparticles for potential application in neutron capture therapy.

  2002cites this paper